Fkbp4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| FKBP4 Protein |
|---|
| Protein Name | FK506 Binding Protein 4 (FKBP52) |
| Gene | FKBP4 |
| UniProt ID | Q02790 |
| Molecular Weight | 51.2 kDa |
| Subcellular Localization | Cytoplasm, Nucleus |
| Protein Family | FKBP Family |
| Length | 459 amino acids |
FKBP4 (FK506 Binding Protein 4), also known as FKBP52, is a member of the immunophilin family of proteins with peptidyl-prolyl cis-trans isomerase (PPI) activity. FKBP4 functions as both an immunophilin and an Hsp90 co-chaperone, playing critical roles in steroid hormone receptor signaling, protein quality control, and neuronal development. FKBP4 has been implicated in neurodegenerative diseases through its interactions with tau protein and its role in glucocorticoid receptor signaling.
¶ Domain Architecture
FKBP4 contains multiple functional domains:
- FKBP Domain 1 (residues 15-85): N-terminal FKBP domain with PPIase activity
- FKBP Domain 2 (residues 100-170): Second FKBP domain with reduced enzymatic activity
- TPR Domain (residues 350-430): Tetratricopeptide repeat domain mediating Hsp90 binding
- Calcineurin-Binding Region (C-terminal): Mediates immunophilin-like functions
FKBP4 catalyzes cis-trans isomerization of peptidyl-prolyl bonds:
- Protein Folding: Accelerates folding of proline-containing polypeptides
- Conformational Changes: Regulates protein conformation through proline isomerization
FKBP4 regulates Hsp90 chaperone complexes:
- Complex Assembly: Binds to Hsp90 through its TPR domain
- Client Protein Loading: Facilitates loading of client proteins onto Hsp90
- Steroid Receptor Folding: Critical for proper folding of glucocorticoid and other steroid receptors
FKBP4 modulates tau pathology through glucocorticoid signaling:
- Tau Phosphorylation: Modulates tau phosphorylation through glucocorticoid pathways
- Synaptic Plasticity: Regulates synaptic function through glucocorticoid receptor signaling
- Therapeutic Potential: FKBP4 modulators could influence tau pathology
- Alpha-synuclein Aggregation: May influence alpha-synuclein aggregation
- Dopaminergic Neuron Survival: Glucocorticoid signaling modulates neuronal survival
The study of Fkbp4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Haering et al., FKBP family in neuronal signaling (2014)
- Sanchez et al., FKBP52 and neurodegeneration (2012)
- Riggs et al., FKBP52 structure and function (2007)
- Pirkl et al., FKBP52 in protein folding (2011)
- Davies et al., Hsp90 co-chaperones in disease (2015)
- Blazer et al., Glucocorticoid signaling in neurodegeneration (2020)
- Juban et al., FKBP52 and tau pathology (2018)
- Schnei et al., Hsp90 inhibition in AD (2019)